Morpheus8 Treatment Protocol for Facial Rejuvenation
Primary Recommendation
For optimal facial rejuvenation with Morpheus8, perform fractional RF microneedling combined with platelet-rich fibrin (PRF) or platelet-rich plasma (PRP), with PRF showing superior outcomes—delivering a 3-fold higher therapeutic response than PRP alone. 1
Treatment Protocol
Session Frequency and Duration
- Administer 3-6 treatment sessions with 2-3 week intervals between each session 2, 3
- Maintenance treatments should be performed every 6 months following the initial treatment course 3
Needle Depth Settings
- Utilize needle depth control precision within the standard range of 0.25-2.5mm depending on treatment area and indication 1
- Deeper settings address skin laxity and scarring, while superficial depths target fine lines and texture 4, 5
Combination Therapy Approach
The evidence strongly supports combining Morpheus8 with adjunctive biologics rather than using RF microneedling alone:
- PRF is the preferred biologic adjunct, showing significantly higher therapeutic response (3-fold) compared to PRP when combined with microneedling 1, 6
- PRF produces higher cumulative release of growth factors with slow, prolonged delivery ideal for tissue regeneration 6
- The combination significantly improves cutaneous spots, wrinkles, pore reduction, and texture with superior patient satisfaction 1
Application Sequence
Critical timing consideration: Always perform RF microneedling FIRST, then immediately apply PRF/PRP 2
- Ablative energy damages cells if biologics are applied beforehand 2
- PRF/PRP can be applied topically, via additional microneedling passes, or as intradermal injection immediately post-RF treatment 2
Absolute Contraindications
Do not perform Morpheus8 in patients with:
- Active skin infections at treatment site 1
- Presence of tattoos or permanent makeup in treatment area 1
- Pregnancy or breastfeeding (standard precaution for aesthetic procedures)
- History of keloid scarring represents a relative contraindication requiring careful risk-benefit assessment, as RF microneedling creates controlled dermal injury that could theoretically trigger keloid formation
Post-Treatment Management
Immediate Care (First 24 Hours)
- Ensure adequate pain management during and after procedure 1
- Patients must avoid sunlight exposure for 24 hours post-procedure 1
- Expect mild adverse events including erythema, edema, pain, burning sensation, and bruising 2
Recovery Timeline
- PRF/PRP combination significantly reduces downtime and inflammation compared to RF microneedling alone 2
- Most patients experience faster recovery with combination therapy versus monotherapy 2
Long-Term Maintenance
- Maintain rigorous sun protection regimen 3
- Advise smoking cessation to maximize and maintain results 3
- Establish good home skincare routine 3
Clinical Outcomes
Histological Changes
The combination of RF microneedling with PRF/PRP produces:
- Increased dermal thickness 2
- Neocollagenosis with enhanced collagen organization 2
- Increased collagen volume and fibroblast activity 2
- Organized collagen bundles with newly formed collagen 7
Patient Satisfaction
- 90-91% of patients report excellent or marked improvement after three treatments 2
- Overall satisfaction rates exceed 90% with PRF combination therapy 2
- Improvement in wrinkles, texture, pores, and skin firmness is statistically significant 2
Device-Specific Advantages
Morpheus8 possesses unique technological properties that differentiate it from other RF microneedling devices, making it a preferred choice for many practices 4
- Effective for various aesthetic and dermatological conditions across all skin types 4
- Addresses concerns where surgical intervention may not be desired 4
Common Pitfalls to Avoid
- Never apply PRF/PRP before RF treatment—this causes cell damage from ablative energy 2
- Do not treat over active infections, tattoos, or permanent makeup 1
- Avoid inadequate sun protection counseling—patients need explicit 24-hour sunlight avoidance instructions 1
- Do not use PRP when PRF is available—PRF demonstrates superior outcomes with 3-fold higher therapeutic response 1, 6